The Patent Finder

Conjuchem Biotechnologies Inc.

Also on record
Records under this name other than patents Conjuchem Biotechnologies Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Conjuchem Biotechnologies Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,087,375Methods of treating or preventing thromboses
Formerly held
Term ended
Term ended Jun 11, 2019 · USPTO record
Term endedTerm ended Jun 11, 2019USPTO record
US 6,107,489Extended lifetimes in vivo renin inhibitors
Formerly held
Term ended
Term ended Mar 12, 2019 · USPTO record
Term endedTerm ended Mar 12, 2019USPTO record
US 6,103,233Cellular and serum protein anchors and conjugates
Formerly held
Term ended
Term ended Aug 15, 2017 · USPTO record
Term endedTerm ended Aug 15, 2017USPTO record
US 6,706,892Pulmonary delivery for bioconjugation
Formerly held
Lapsed on the fee record
Ended Mar 16, 2016 · USPTO record
Lapsed on the fee recordEnded Mar 16, 2016USPTO record
US 8,093,206Methods involving long lasting synthetic exendin-4 peptide conjugates
Formerly held
Lapsed on the fee record
Ended Jan 10, 2016 · USPTO record
Lapsed on the fee recordEnded Jan 10, 2016USPTO record
US 8,084,414Methods involving long lasting synthetic exendin-4-peptide conjugates
Formerly held
Lapsed on the fee record
Ended Dec 27, 2015 · USPTO record
Lapsed on the fee recordEnded Dec 27, 2015USPTO record
US 8,080,516Long lasting synthetic exendin-4 peptide conjugates
Formerly held
Lapsed on the fee record
Ended Dec 20, 2015 · USPTO record
Lapsed on the fee recordEnded Dec 20, 2015USPTO record
US 7,307,148Method for purification of albumin conjugates
Formerly held
Lapsed on the fee record
Ended Dec 11, 2015 · USPTO record
Lapsed on the fee recordEnded Dec 11, 2015USPTO record
US 8,039,432Method of treatment of diabetes and/or obesity with reduced nausea side effect
Formerly held
Lapsed on the fee record
Ended Oct 18, 2015 · USPTO record
Lapsed on the fee recordEnded Oct 18, 2015USPTO record
US 7,268,113Long lasting growth hormone releasing factor derivatives
Formerly held
Lapsed on the fee record
Ended Sep 11, 2015 · USPTO record
Lapsed on the fee recordEnded Sep 11, 2015USPTO record
10 of 38 patents shown.
Pro members see all 38.
Pro members: see all 38 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited